Latest Ipo And Capital Raising News

Advanced Energy Minerals reports a sharp revenue increase alongside a substantial net loss for 2025, completing a major plant expansion and raising $44.8 million in its IPO.

Epiminder Limited has successfully listed on the ASX, raising $125 million to commercialise its FDA-approved Minder device. The company has initiated the first US implant and secured five leading medical centres for its DETECT study.

Findi Limited has landed a significant pre-IPO investment from Nova Global Opportunities Fund PCC, setting the stage for its Indian subsidiary’s planned listing on the Bombay Stock Exchange by FY27. This deal supports a Findi share price target between $5.58 and $6.69.

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

Green & Gold Minerals has successfully listed on the ASX, raising $5.7 million to fund drilling at its Chillagoe Gold Project, with initial results expected soon. The company also holds promising critical minerals prospects in Queensland.

Tetratherix Limited reports its first financial results as a listed company, revealing a $9.4 million statutory loss driven by R&D and listing costs, alongside a robust $29.3 million cash position post-IPO. The company highlights key operational milestones and outlines strategic plans to accelerate commercialisation across its innovative biomaterial platform.

WAM Active Limited reported a robust 26.4% increase in its investment portfolio for FY2025, significantly outperforming key benchmarks, while maintaining its fully franked dividend at 6.0 cents per share.

StepChange Holdings Limited reported a $2.69 million loss for its inaugural financial period ending June 2025, completed a significant $18.3 million acquisition, and successfully listed on the ASX in July 2025.

LinQ Minerals Limited has filed a Replacement Prospectus for its IPO to raise up to $10 million, anchored by its 100%-owned Gilmore Project in NSW with a substantial 2024 Mineral Resource Estimate. The company aims to advance exploration and development of this significant gold-copper asset in a tier-1 jurisdiction.

Legacy Iron Ore Limited announces a significant leadership reshuffle with CEO Rakesh Gupta stepping down immediately and Dr Ranajit Das appointed to lead the company from July 2025. Ben Donovan also joins the board as a Non-Executive Director.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.